Fresenius SE (FREd)
FRA • Healthcare
July 10, 2026 at 15:30 UTC
About Fresenius SE
Fresenius SE & Co. KGaA, listed on XETRA under FRE.DE, is a healthcare company focused on dialysis, hospital management, outpatient medical care, and clinical care products. In FY2025 it generated EUR 22.9 billion in revenue. The group operates across care facilities, therapeutic products, and healthcare project services, with roots going back to 1912.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Fresenius SE's Technical Indicators Summary
| Indicator | Value |
|---|---|
RSI (14) | 65.57 |
Stochastic %K (14, 3, 3) | 67.40 |
CCI (20) | 96.10 |
WPR (14) | -30.36 |
Momentum (10) | 2.75 |
MFI | 75.41 |
MACD Level (12, 26) | 1.06 |
Bollinger Bands | $37.58 - $43.80 |
ATR (14) | $0.90 (2.11%) |
ADX (14) | 33.42 |
OBV | 16,139,654 |
Classic Pivot Point | $42.42 |
Fibonacci Pivot Point | $42.42 |
Simple Moving Averages | $39.27 - $45.42(5 indicators) |
Exponential Moving Averages | $40.55 - $43.74(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The session ended with FREd modestly above yesterday’s 42.22, maintaining its 1.18% gap. Closing turnover for FREd remained on the soft side, running 0.38× typical levels. FREd gains as Fresenius confirms plans to cut debt and streamline its portfolio.
Trading Volume
Below avg (1.1M)
400.3K
vs S&P 500 Today
Outperforming Market
+1.14%
52-Week Position
Mid-range
42.6%
Updated: July 10, 2026 at 15:02 UTC